Immunogenicity and safety of 13-valent pneumococcal conjugate vaccine (PCV13) formulated with 2-phenoxyethanol in multidose vials given with routine vaccination in healthy infants: An open-label randomized controlled trial-Reference-Cited by-同舟云学术

Immunogenicity and safety of 13-valent pneumococcal conjugate vaccine (PCV13) formulated with 2-phenoxyethanol in multidose vials given with routine vaccination in healthy infants: An open-label randomized controlled trial

Published:2017-05 Issue:24 Volume:35 Page:3256-3263
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Idoko Olubukola T.,Mboizi Robert B.,Okoye Michael,Laudat France,Ceesay Bubacarr,Liang John Z.,Le Dren-Narayanin Natacha,Jansen Kathrin U.,Gurtman Alejandra,Center Kimberly J.,Scott Daniel A.,Kampmann Beate,Roca Anna

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference30 articles.

1. Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates;O'Brien;Lancet,2009

2. Epidemiological and molecular characteristics of a highly lethal pneumococcal meningitis epidemic in Burkina Faso;Yaro;Clin Infect Dis,2006

3. An outbreak of serotype 1 Streptococcus pneumoniae meningitis in northern Ghana with features that are characteristic of Neisseria meningitidis meningitis epidemics;Leimkugel;J Infect Dis,2005

4. Invasive pneumococcal disease among infants before and after introduction of pneumococcal conjugate vaccine;Poehling;JAMA,2006

5. Indirect effects associated with widespread vaccination of infants with heptavalent pneumococcal conjugate vaccine (PCV7; Prevnar);Isaacman;Vaccine,2007

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Microtiter Plate-Based Differential Scanning Fluorimetry: A High-Throughput Method for Efficient Formulation Development;Journal of Pharmaceutical Sciences;2022-08

2. Safety and immunogenicity of a multidose vial formulation of 13-valent pneumococcal conjugate vaccine administered with routine pediatric vaccines in healthy infants in India: A phase 4, randomized, open-label study;Vaccine;2021-11

3. Introduction of multi-dose PCV 13 vaccine in Benin: from the decision to vaccinators experience;BMC Public Health;2020-08-08

4. Associations between geographic region and immune response variations to pneumococcal conjugate vaccines in clinical trials: A systematic review and meta-analysis;International Journal of Infectious Diseases;2020-03

5. Safety and immunogenicity of a novel 10-valent pneumococcal conjugate vaccine candidate in adults, toddlers, and infants in The Gambia—Results of a phase 1/2 randomized, double-blinded, controlled trial;Vaccine;2020-01